SFTPC and pulmonary fibrosis: This hypothesis is supported by the observation that lung fibrosis occurs following ablation of alveolar type II in genetically modified mice using diphtheria toxin (DT) receptor transgene under the control of Sftpc promoter (Sisson et al., 2010).